WO2015025331A3 - Drug designing for diabetes mellitus using pentacosanoic acid. - Google Patents

Drug designing for diabetes mellitus using pentacosanoic acid. Download PDF

Info

Publication number
WO2015025331A3
WO2015025331A3 PCT/IN2014/000518 IN2014000518W WO2015025331A3 WO 2015025331 A3 WO2015025331 A3 WO 2015025331A3 IN 2014000518 W IN2014000518 W IN 2014000518W WO 2015025331 A3 WO2015025331 A3 WO 2015025331A3
Authority
WO
WIPO (PCT)
Prior art keywords
diabetes mellitus
pentacosanoic acid
drug designing
decoction
drug
Prior art date
Application number
PCT/IN2014/000518
Other languages
French (fr)
Other versions
WO2015025331A2 (en
Inventor
Uma Makheswari M.
Original Assignee
M Uma Makheswari
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by M Uma Makheswari filed Critical M Uma Makheswari
Publication of WO2015025331A2 publication Critical patent/WO2015025331A2/en
Publication of WO2015025331A3 publication Critical patent/WO2015025331A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to the drug designing performed for the treatment of Diabetes mellitus Type 1 and 2 using a compound Pentacosanoic acid. It is used for the prevention and management of hyperglycemia, abnormal lipids, obesity, hypertension and atherosclerosis involved with diabetic patients. It may enable the design of therapy that can control, treat, and prevent Diabetes mellitus. It can be formulated in a form consisting of decoction, dried decoction, infusion, tincture, dried extract, capsule, tablet, syrup or the like thereof.
PCT/IN2014/000518 2013-08-21 2014-08-08 Drug designing for diabetes mellitus using pentacosanoic acid. WO2015025331A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3687/CHE/2013 2013-08-21
IN3687CH2013 2013-08-21

Publications (2)

Publication Number Publication Date
WO2015025331A2 WO2015025331A2 (en) 2015-02-26
WO2015025331A3 true WO2015025331A3 (en) 2015-07-02

Family

ID=52484234

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2014/000518 WO2015025331A2 (en) 2013-08-21 2014-08-08 Drug designing for diabetes mellitus using pentacosanoic acid.

Country Status (1)

Country Link
WO (1) WO2015025331A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109827920A (en) * 2018-12-29 2019-05-31 南京同凯兆业生物技术有限责任公司 The detection method of reduced sugar in a kind of Penicillium citrinum fermentation liquid
CN115068461B (en) * 2022-06-07 2023-06-20 仲恺农业工程学院 Application of pentadecanoic acid in preparation of preparation for promoting angiogenesis of sow placenta

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293001A2 (en) * 1987-05-29 1988-11-30 Lion Corporation Method for continuous preparation of highly pure monoglyceride

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0293001A2 (en) * 1987-05-29 1988-11-30 Lion Corporation Method for continuous preparation of highly pure monoglyceride

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NESTOR M. CARBALLEIRA ET AL.: "Identification and Total Synthesis of Novel Fatty Acids from the Caribbean Sponge Calyx podatypa", JOURNAL OF NATURAL PRODUCTS, vol. 61, no. 8, 1998, pages 1049 - 1052 *
NESTOR M. CARBALLEIRA ET AL.: "Two Novel Iso-Branched Octadecenoic Acids from a Micrococcus Species", JOURNAL OF NATURAL PRODUCTS, vol. 63, no. 11, 2000, pages 1573 - 1575 *

Also Published As

Publication number Publication date
WO2015025331A2 (en) 2015-02-26

Similar Documents

Publication Publication Date Title
MX2013004699A (en) Pharmaceutical combinations for the treatment of metabolic disorders.
WO2012055967A3 (en) Treating diabetes melitus using insulin injections administered with varying injection intervals
WO2011018501A3 (en) Composition including an unsaponifiable fraction
JP2017515499A5 (en)
CN105341928A (en) Health-care food capable of reducing blood sugar
JOP20210201A1 (en) Blood glucose lowering compound
GB201318936D0 (en) Pharmaceutical compostion for controlling blood sugar, blood lipid and body weight
WO2015121457A8 (en) Fgf-8 for use in treating diseases or disorders of energy homeostasis
WO2015025331A3 (en) Drug designing for diabetes mellitus using pentacosanoic acid.
WO2016190566A3 (en) Pharmaceutical composition or functional health food for preventing and treating metabolic diseases, containing water extract of pleurotus eryngii var. ferulae (pf.) as active ingredient
WO2011052935A3 (en) Composition for lowering blood sugar, comprising extract of smilax chine l., momordica charantia and cordyceps militaris as active ingredient
WO2012019435A3 (en) Composition for treating neurodegenerative disease or neuropathological condition
NZ708511A (en) Methods for controlling blood pressure and reducing dyspnea in heart failure
WO2014018763A3 (en) Method of treating type i diabetes using apolipoprotein aiv
WO2012138146A3 (en) Composition containing heat-treated powder or extract of glycine soja as active gradient for prevention and treatment of diabetes mellitus and diabetic complications
WO2014066400A3 (en) Methods for the effective treatment of metastatic cancer
WO2012141615A3 (en) Medicament
WO2010148533A8 (en) A pharmaceutical composition with the effect of treating diabetes
WO2017220051A3 (en) Benserazide hydrochloride pharmaceutical composition and medical use thereof for lowering blood sugar
WO2013188876A3 (en) Methods for modulating kallikrein (klkb1) expression
EP2684566A4 (en) Pharmaceutical composition for preventing and treating complications of diabetes containing a traditional oriental medicine extract or a fraction thereof as an active ingredient
WO2014185641A3 (en) Method for preparing health food supplement containing aster scaber
CN104922490A (en) Traditional Chinese medicine special for treating gastrorrhagia
CN105726718A (en) A traditional Chinese medicine for treating lumbago caused by traumatic injuries
WO2014155268A3 (en) Fgf-r tyrosine kinase activity inhibitors - use in diseases associated with lack of or reduced snf5 activity

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 14837377

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 14837377

Country of ref document: EP

Kind code of ref document: A2